EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a hematological malignancy representing one-third of non-Hodgkin’s lymphoma cases. Notwithstanding immunotherapy in combination with chemotherapy (R-CHOP) is an effective therapeutic approach for DLBCL, a subset of patients encounters treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales: Turdo, Alice, Gaggianesi, Miriam, D’Accardo, Caterina, Porcelli, Gaetana, Bella, Sebastiano Di, Cricchio, Dario, Pillitteri, Irene, Porcasi, Rossana, Lo Iacono, Melania, Verona, Francesco, Modica, Chiara, Roozafzay, Narges, Florena, Ada Maria, Stassi, Giorgio, Mancuso, Salvatrice, Todaro, Matilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682075/
https://www.ncbi.nlm.nih.gov/pubmed/38035116
http://dx.doi.org/10.3389/fimmu.2023.1266265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682075/
https://www.ncbi.nlm.nih.gov/pubmed/38035116
http://dx.doi.org/10.3389/fimmu.2023.1266265

Ejemplares similares